Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

MeCHaNiSM · Mechanical Characterisation of Nucleic Acids using Single Molecule Methods

HORIZONStatus: SIGNED1 October 202430 September 2028EU funding €4,085,935Call HORIZON-MSCA-2023-DN-01

Nucleic acid (NAs)-based therapies have started to yield major advances in the treatment of human disease. New approaches for understanding NA structure and function are required to extend the boundaries of today’s gene editing technologies, cancer therapies, and mRNA vaccines. Single-molecule techniques have revolutionised our understanding of NAs and their interactions with therapeutic oligonucleotides, small molecules, and proteins. However, for Europe to remain competitive in this area, new expertise is urgently required in single-molecule NA analysis, which intersects the fields of physical chemistry, biophysics, NA synthesis, and computation. MeChaNiSM will train the next generation of European scientific leaders in the development and use of single-molecule biophysics techniques where they will investigate critical interrelated question regarding the structure, dynamics, function, and interactions of NAs. To do this, our Doctoral Candidates (DCs) will:- Unravel high-resolution NA structures and intramolecular forces with modified bases- Understand the conformation and dynamics of NAs at the single-molecule level- Develop next-generation therapeutics for treating genetic diseasesMeChaNiSM connects world-leading researchers working in the fields of single-molecule biophysics, NA chemistry, and computational modeling with outstanding industrial partners working in complementary fields. In addition to conducting world-class research, our DCs will understand industrial needs, have know-how in running multidisciplinary research, and will be immersed in a broad collaborative network connecting academia and industry. Our DCs will provide vital future breakthrough applications in NAs and single-molecule analysis to pharmaceutical and biotechnological industries where the design of new drugs - including NA-based therapeutics and vaccine technologies - will provide major improvements to human health.

Consortium · 12 organisations

coordinator

CHALMERS TEKNISKA HOGSKOLA AB

SE · €881,129

participant

STICHTING VU

NL · €274,370

participant

DUBLIN CITY UNIVERSITY

IE · €572,976

associatedPartner

LUMICKS BV

NL

associatedPartner

NANOTEMPER TECHNOLOGIES GMBH

DE

associatedPartner

ASTRAZENECA AB

SE

participant

UNIVERSITAT ZU KOLN

DE · €521,078

participant

UNIVERSITAT DE BARCELONA

ES · €503,942

participant

UNIVERSITAET AUGSBURG

DE · €521,078

associatedPartner

NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED

IE

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €262,620

participant

UNIVERSITEIT VAN AMSTERDAM

NL · €548,741

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.